Cingulate (CING) insider granted 7,334 options at $3.92
Cingulate Inc. (CING) reported an insider equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cingulate Inc. (CING) reported an insider equity grant. On 09/30/2025, EVP and CSO Raul Silva received a stock option covering 7,334 shares of common stock at an exercise price of $3.92, expiring 09/30/2035. The filing lists transaction code “A,” indicating an award. The option was granted pursuant to Dr. Silva’s Employment Agreement, as amended, and is held directly. Following the grant, 7,334 derivative securities were beneficially owned.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to Buy) | 7,334 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cingulate (CING) report?
What was the exercise price of the granted options for CING?
When did the Cingulate insider transaction occur?
What is the expiration date of the Cingulate options granted?
What was the Form 4 transaction code for the Cingulate filing?
How many derivative securities were beneficially owned after the transaction?
What is Raul Silva’s role at Cingulate (CING)?
AI-generated analysis. How Rhea-AI works. Not financial advice.